Most commonly prescribed glaucoma drug reduces risk of vision loss by more than 50% over 2 years
Friday, December 19, 2014 - 02:30
in Health & Medicine
“Medication to lower raised eye pressure has been used for decades as the main treatment for OAG to delay progressive vision loss. But, until now, the extent to which the most frequently prescribed class of pressure-lowering drugs (prostaglandin analogues) have a protective effect on vision was not known," explains the lead author of a new study. “Our findings offer solid proof to patients and practitioners that the visual deterioration caused by glaucoma can be reduced using this treatment.”